405 related articles for article (PubMed ID: 8497231)
1. Effect of head phantom size on 10B and 1H[n,gamma]2H dose distributions for a broad field accelerator epithermal neutron source for BNCT.
Gupta N; Niemkiewicz J; Blue TE; Gahbauer R; Qu TX
Med Phys; 1993; 20(2 Pt 1):395-404. PubMed ID: 8497231
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo-based treatment planning for boron neutron capture therapy using custom designed models automatically generated from CT data.
Zamenhof R; Redmond E; Solares G; Katz D; Riley K; Kiger S; Harling O
Int J Radiat Oncol Biol Phys; 1996 May; 35(2):383-97. PubMed ID: 8635948
[TBL] [Abstract][Full Text] [Related]
3. A feasibility study of a deuterium-deuterium neutron generator-based boron neutron capture therapy system for treatment of brain tumors.
Hsieh M; Liu Y; Mostafaei F; Poulson JM; Nie LH
Med Phys; 2017 Feb; 44(2):637-643. PubMed ID: 28205309
[TBL] [Abstract][Full Text] [Related]
4. Designing accelerator-based epithermal neutron beams for boron neutron capture therapy.
Bleuel DL; Donahue RJ; Ludewigt BA; Vujic J
Med Phys; 1998 Sep; 25(9):1725-34. PubMed ID: 9775379
[TBL] [Abstract][Full Text] [Related]
5. Interaction between the biological effects of high- and low-LET radiation dose components in a mixed field exposure.
Mason AJ; Giusti V; Green S; Munck af Rosenschöld P; Beynon TD; Hopewell JW
Int J Radiat Biol; 2011 Dec; 87(12):1162-72. PubMed ID: 21923301
[TBL] [Abstract][Full Text] [Related]
6. Calculation of dose components in head phantom for boron neutron capture therapy.
da Silva AX; Crispim VR
Cell Mol Biol (Noisy-le-grand); 2002 Nov; 48(7):813-7. PubMed ID: 12622057
[TBL] [Abstract][Full Text] [Related]
7. Boron self-shielding effects on dose delivery of neutron capture therapy using epithermal beam and boronophenylalanine.
Ye SJ
Med Phys; 1999 Nov; 26(11):2488-93. PubMed ID: 10587238
[TBL] [Abstract][Full Text] [Related]
8. Dose homogeneity in boron neutron capture therapy using an epithermal neutron beam.
Konijnenberg MW; Dewit LG; Mijnheer BJ; Raaijmakers CP; Watkins PR
Radiat Res; 1995 Jun; 142(3):327-39. PubMed ID: 7761583
[TBL] [Abstract][Full Text] [Related]
9. Boron neutron capture therapy (BNCT): implications of neutron beam and boron compound characteristics.
Wheeler FJ; Nigg DW; Capala J; Watkins PR; Vroegindeweij C; Auterinen I; Seppälä T; Bleuel D
Med Phys; 1999 Jul; 26(7):1237-44. PubMed ID: 10435523
[TBL] [Abstract][Full Text] [Related]
10. Validation of dose planning calculations for boron neutron capture therapy using cylindrical and anthropomorphic phantoms.
Koivunoro H; Seppälä T; Uusi-Simola J; Merimaa K; Kotiluoto P; Serén T; Kortesniemi M; Auterinen I; Savolainen S
Phys Med Biol; 2010 Jun; 55(12):3515-33. PubMed ID: 20508317
[TBL] [Abstract][Full Text] [Related]
11. Design for an accelerator-based orthogonal epithermal neutron beam for boron neutron capture therapy.
Allen DA; Beynon TD; Green S
Med Phys; 1999 Jan; 26(1):71-6. PubMed ID: 9949400
[TBL] [Abstract][Full Text] [Related]
12. An investigation of the possibilities of BNCT treatment planning with the Monte Carlo method.
Konijnenberg MW; Mijnheer BJ; Raaijmakers CP; Stecher-Rasmussen F; Watkins PR
Strahlenther Onkol; 1993 Jan; 169(1):25-8. PubMed ID: 8434336
[TBL] [Abstract][Full Text] [Related]
13. Computational assessment of deep-seated tumor treatment capability of the 9Be(d,n)10B reaction for accelerator-based boron neutron capture therapy (AB-BNCT).
Capoulat ME; Minsky DM; Kreiner AJ
Phys Med; 2014 Mar; 30(2):133-46. PubMed ID: 23880544
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo calculations of epithermal boron neutron capture therapy with heavy water.
Wallace SA; Allen BJ; Mathur JN
Phys Med Biol; 1995 Oct; 40(10):1599-608. PubMed ID: 8532742
[TBL] [Abstract][Full Text] [Related]
15. An accelerator-based epithermal neutron beam design for BNCT and dosimetric evaluation using a voxel head phantom.
Lee DJ; Han CY; Park SH; Kim JK
Radiat Prot Dosimetry; 2004; 110(1-4):655-60. PubMed ID: 15353726
[TBL] [Abstract][Full Text] [Related]
16. Development of a dual phantom technique for measuring the fast neutron component of dose in boron neutron capture therapy.
Sakurai Y; Tanaka H; Kondo N; Kinashi Y; Suzuki M; Masunaga S; Ono K; Maruhashi A
Med Phys; 2015 Nov; 42(11):6651-7. PubMed ID: 26520755
[TBL] [Abstract][Full Text] [Related]
17. Feasibility study on epithermal neutron field for cyclotron-based boron neutron capture therapy.
Yonai S; Aoki T; Nakamura T; Yashima H; Baba M; Yokobori H; Tahara Y
Med Phys; 2003 Aug; 30(8):2021-30. PubMed ID: 12945968
[TBL] [Abstract][Full Text] [Related]
18. Feasibility study of optical imaging of the boron-dose distribution by a liquid scintillator in a clinical boron neutron capture therapy field.
Maeda H; Nohtomi A; Hu N; Kakino R; Akita K; Ono K
Med Phys; 2024 Jan; 51(1):509-521. PubMed ID: 37672219
[TBL] [Abstract][Full Text] [Related]
19. Use of low-pressure tissue equivalent proportional counters for the dosimetry of neutron beams used in BNCT and BNCEFNT.
Kota C; Maughan RL; Tattam D; Beynon TD
Med Phys; 2000 Mar; 27(3):535-48. PubMed ID: 10757605
[TBL] [Abstract][Full Text] [Related]
20. Influence of Neutron Sources and 10B Concentration on Boron Neutron Capture Therapy for Shallow and Deeper Non-small Cell Lung Cancer.
Yu H; Tang X; Shu D; Liu Y; Geng C; Gong C; Hang S; Chen D
Health Phys; 2017 Mar; 112(3):258-265. PubMed ID: 28121726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
